Home / Agomelatine / Czechia
CZ ATC N06AX22 · updated 2 Nov 2026
Agomelatine shortage in Czechia
Is there an Agomelatine shortage in Czechia?
Yes. As of 2 Nov 2026, 3 Agomelatine products are reported short in Czechia, the first since 27 Apr 2026. The company estimate for the return is 1 Jan 2027 (latest 3 Jan 2028). Main reason: commercial decision or withdrawal.
Not reported short in any other country we track. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | AGOMELATIN +PHARMA 25MG 25MG TBL FLM 98 | +pharma arzneimittel gmbh, Graz | 27 Apr 2026 | 1 Jan 2027 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | AGOMELATIN +PHARMA 25MG 25MG TBL FLM 90 | +pharma arzneimittel gmbh, Graz | 1 Jul 2026 | 3 Jan 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
| CZ | AGOMELATINE GLENMARK 25MG 25MG TBL FLM 28 anticipated | Glenmark Pharmaceuticals s.r.o., Praha | 9 Nov 2026 | 1 Jan 2028 | Commercial decision or withdrawal Obchodní/marketingové důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.